Hemagglutinin-esterase cannot be considered as a candidate for designing drug against COVID-19.
Mol Divers
; 25(3): 1999-2000, 2021 Aug.
Article
in English
| MEDLINE | ID: covidwho-1303350
ABSTRACT
We read with interest the article by Patel et al. on the identification of potential inhibitors of coronavirus hemagglutinin-esterase. The authors considered hemagglutinin-esterase as a glycoprotein of SARS-CoV-2 and selected hemagglutinin-esterase as a target to identify potential inhibitors using a combination of various computational approaches, and however, SARS-CoV-2 genome lacks hemagglutinin-esterase gene; thus, hemagglutinin-esterase does not exist in SARS-CoV-2 particle.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Drug Design
/
Molecular Targeted Therapy
/
COVID-19 Drug Treatment
Language:
English
Journal:
Mol Divers
Journal subject:
Molecular Biology
Year:
2021
Document Type:
Article
Affiliation country:
S11030-021-10272-w
Similar
MEDLINE
...
LILACS
LIS